Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

The Company Behind Tylenol Tries to Navigate Its Latest Crisis

Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Drugs (Pharmaceuticals), Intellectual Disabilities, Johnson & Johnson, Kennedy, Robert F Jr, Mergers, Acquisitions and Divestitures, Pain-Relieving Drugs, Recalls and Bans of Products, Trump, Donald J, Tylenol (Drug)
←Jimmy Kimmel’s Show to Return to ABC on Tuesday Night
Make T Something | Nonamey→

More posts

  • Ngumoha stars as Liverpool thrash 10-man Man Utd

  • Gabbriette Bechtel and Matty Healy Are Expecting Their First Baby!

  • Trump blames $6T stock market slide on Democrats’ midterm wins

  • Taylor Swift Celebrates Travis Kelce’s Touchdown With Niece, Her Parents, Donna & Kylie Kelce

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube